COVID-19 in people with Cystic Fibrosis beyond the pre-omicron era: a prospective study with a specific focus on long COVID
- 3 September 2025
- journal article
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 25 (1) , 172-178
Abstract
No abstract availableKeywords
Funding Information
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Ministero dell'Università e della Ricerca
This publication has 25 references indexed in Scilit:
- Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort studyJournal of Cystic Fibrosis, 2024
- Prevalence and risk factors for persistent symptoms after COVID-19: a systematic review and meta-analysisClinical Microbiology and Infection, 2023
- CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosisThe Lancet, 2023
- SARS‐CoV‐2 infection in children with cystic fibrosis: A cross‐sectional multicenter study in Spain. New waves, new knowledgePediatric Pulmonology, 2023
- Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2The Lancet, 2022
- Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational studyJournal of Cystic Fibrosis, 2022
- Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis SocietyInfection, 2021
- The global impact of SARS-CoV-2 in 181 people with cystic fibrosisJournal of Cystic Fibrosis, 2020
- Impact of COVID-19 on people with cystic fibrosisThe Lancet Respiratory Medicine, 2020
- Impact of the A (H1N1) pandemic influenza (season 2009–2010) on patients with cystic fibrosisJournal of Cystic Fibrosis, 2011